Autoimmune Diseases  >>  pateclizumab (RG7416)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pateclizumab (RG7416) / Roche
NCT01225393 / 2010-021577-37: A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis

Checkmark EULAR 2013
May 2013 - May 2013: EULAR 2013
Completed
2
211
US, Europe, RoW
MLTA3698A, adalimumab, leflunomide, methotrexate, placebo
Genentech, Inc.
Rheumatoid Arthritis
07/12
 

Download Options